Fortis Malar Hospitals Ltd Q2 FY26 – Zero Scalpel, Full Drama: From Surgery to Slump Sale to Open Offer!

1. At a Glance

Fortis Malar Hospitals Ltd (FMHL) — once a respected Chennai-based multispeciality hospital — is now a corporate ghost in scrubs. With a market cap of ₹117 crore and a current price of ₹62.6, the company technically exists but operationally doesn’t. It used to treat patients; now it treats regulatory filings.

In February 2024, Fortis Malar sold off its entire business operations to MGM Healthcare Pvt. Ltd. for ₹45.7 crore, effectively putting itself on a hospital bed of its own making. Since then, the company has reported sales of barely ₹0.03 crore (basically a rounding error) and a PAT of ₹0.01 crore this quarter — down 89% QoQ, and even Excel refused to calculate the YoY variation.

Yet, despite being a business-free business, it still trades at a P/E of 25.9, a price-to-book of 3.41, and a ROE of 0.56% — because, apparently, nostalgia also gets priced in the market. Promoter holding stands tall at 62.7%, while retail shareholders wait for a miracle, or at least a press release.

2. Introduction

Once upon a fiscal year, Fortis Malar Hospitals was Chennai’s pride — surgeons slicing, machines beeping, and cash registers ringing. But in 2024, it did something most hospitals don’t: it declared itself clinically dead on the operational front and sold the organs (aka assets) for ₹45.7 crore to MGM Healthcare.

Now, Fortis Malar has zero patients, zero surgeries, and almost zero revenue. The only steady pulse? Interest income on fixed deposits. The latest numbers show 92% of income coming from bank interest and 8% from old provisions written back. That’s not a hospital — that’s a glorified savings account with a BSE ticker.

Meanwhile, its parent company, Fortis Healthcare Ltd, got busy being wooed by IHH Healthcare Berhad, the Malaysian medical giant. As part of the regulatory circus, IHH had to make an open offer for Fortis Malar too — 26% of shares at a price of ₹17.6 per share.

If you’re wondering why a company with no active hospital still trades at ₹62+, welcome to the Indian small-cap market — where sentiment has more ICU beds than logic.

3. Business Model – WTF Do They Even Do?

Let’s keep it simple — they used to run a hospital, and now they don’t.

Fortis Malar Hospitals Ltd, incorporated in 1992, was once a bustling multispeciality setup under the Fortis umbrella. It operated out of a property owned by a sister concern, Fortis Health Management Ltd, and specialized in everything from cardiology to neurology. But then came February 1, 2024 — the date it sold its entire operations to MGM Healthcare.

What’s left?

• No patients.
• No doctors.
• No medical staff.
• Only auditors, lawyers, and compliance officers — the true heroes of post-sale existence.

Currently, the company is evaluating “corporate restructuring options.” Translation: trying to figure out what to do with ₹45 crore cash and a listed shell.

In short, Fortis Malar went from treating diseases to being one — the chronic case of “Existence Without Purpose Ltd.”

4. Financials Overview

Commentary:
Fortis Malar’s numbers look like a hospital ECG post cardiac arrest